Medicine for treating schizophrenia and preparation method thereof

Abstract

The invention discloses a medicine for treating schizophrenia and a preparation method of the medicine, belonging to the field of traditional Chinese medicines. The effective components of the medicine are prepared from the following raw materials: areca-nut, rhizoma acori graminei, lycopodiastrum casuarinoides, hematoxylon, broad-leaved epiphyllum, gastrodia elata, spina gleditsiae, camphor, rhizoma alismatis, immature bitter orange, human placenta, hawthorn, murdanniadivergens, crotalaria assamica, leonurus pseudo-macranthus and burmann cinnamon bark. The medicine disclosed by the invention selects high-quality traditional Chinese medicine materials which are proportioned scientifically, has the effects of smoothening the nerve, reducing heat to remove phlegm, smoothening the live to remove stasis and promoting qi circulation to relieve pain, has remarkable curative effects on symptoms of upset, anxiety, insomnia, amnesia climacteric symptoms and the like caused by schizophrenia, and is convenient to take, good in drug resistance, low in cost, free of toxic or side effect and worthy of wide clinical popularization and application as the diseases do not reoccur after being healed.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a medicine for treating schizophrenia and a preparation method thereof. Background technique [0002] Schizophrenia is a group of severe mental illnesses of unknown etiology, mostly in young adults with slow or subacute onset, clinically manifested as a syndrome with various symptoms, involving obstacles in perception, thinking, emotion, and behavior and incoordination of mental activity. Patients generally have clear consciousness and basically normal intelligence, but some patients may experience cognitive impairment during the course of the disease. The course of the disease is generally protracted, showing recurrent attacks, aggravation or deterioration, and some patients eventually develop decline and mental disability, but some patients can maintain recovery or basically recovery after treatment. [0003] Schizophrenia is a clinical syndrome composed of a grou...

AI Technical Summary

Problems solved by technology

Clozapine, the first-generation and atypical antipsychotic drug, is used as a second-line drug; some patients in the acute stage or patients with poor curative effect can be combined with electric convulsion therapy; Most other patients only suppress their disease temporarily, and relapse after stopping the drug, and the effect is extremely unstable.

Images